



What is an acid? The first step to understand the evolution of
ideas in acid–base physiology since the beginning of the
twentieth century is to examine the definitions of an acid. There
are many current definitions of an acid used in chemistry [1–3].
The word acid is derived from the Latin word ‘acidus’ [2,3],
meaning sour. For most of history ‘sourness’ has been the
defining feature of acids as well as the method for detecting
the presence of acids. Other definitions of acids include the
ability to produce colour changes in litmus and to negate the
effects of an alkali. Several solution-based definitions have
been described since the late nineteenth century.
Arrhenius [4,5] developed a definition in the 1880s that, in its
generalized form, defines an acid as a substance that, when
dissolved in water, produces an increased concentration of
hydrogen ions [2]. Arrhenius also used a more specific
definition of acids as hydrogen salts [6]. By 1900, Naunyn [5]
and other workers [7] had adopted an acid definition that
appears to combine the generalized Arrhenius definition with
Faraday’s earlier description of anions such as chloride as
acid forming and of metal cations such as sodium as base
forming. Naunyn proposed that the acid–base status was
partly determined by electrolytes, particularly sodium and
chloride. This definition was embraced around 1920 by Van
Slyke [8] and is now known as the Van Slyke definition [9].
After World War I, Bronsted and Lowry simultaneously, but
separately, developed an identical definition for acids. Under
the Bronsted–Lowry definition an acid is a substance that
could donate a proton (a hydrogen ion) [1,2]. An acid HA will
donate a proton to the solution when it dissociates into a
hydrogen ion and the conjugate anion A–:
HA ↔ H+ + A–
Lewis developed a further definition in the 1920s, to
embrace a wider range of chemical scenarios. Lewis defined
an acid as a substance that can accept a pair of electrons to
form a covalent bond [1,2]. Chemicals such as boron
trifluoride are Lewis acids. Organic chemists often use this
definition [2].
The validity of a given acid definition [1,2] depends on the
given situation, be it cooking (sourness) or organic chemistry
(Lewis) [2]. In biological solutions such as plasma, the given
situation is a water-based solution with tightly controlled
solute concentrations. Both the Van Slyke and Bronsted–
Lowry definitions (as well as those of Arrhenius and Lewis)
are valid for plasma [9] because water can supply hydrogen
and hydroxyl ions:
H2O ↔ H+ + OH–
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The history of assessing the acid–base equilibrium and associated disorders is intertwined with the
evolution of the definition of an acid. In the 1950s clinical chemists combined the Henderson–
Hasselbalch equation and the Bronsted–Lowry definition of an acid to produce the current bicarbonate
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albumin), pushes bicarbonate into a minor role as an acid–base indicator rather than as an important
mechanism. The Stewart approach may offer new insights into acid–base disorders and therapies.
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The Arrhenius, Bronsted–Lowry, and Lewis definitions are all
currently used in chemistry and provide increasing generaliza-
bility when moving from Arrhenius to Bronsted–Lowry to
Lewis [2,9]. The Bronsted–Lowry definition has been the
most popular among acid–base physiologists since about
1955 [5,9]. However, some of the most important develop-
ments in the evolution of acid–base physiology occurred
before the publication of the Bronsted–Lowry theory in 1923.
Before 1923 the Van Slyke definition (although not so-called
at the time) was the leading definition of an acid for
physiologists [9]. These physiologists included Henderson in
1908 [10] and Hasselbalch in 1916 [4] while developing the
Henderson–Hasselbalch equation (Fig. 1).
The original Henderson–Hasselbalch equation mathematically
links the variables of pH, partial pressure of carbon dioxide
(carbonic acid), and bicarbonate concentration (Fig. 1) [11].
This equation relates pH with the ratio of the concentration of
undissociated acid HA to the concentration of the conjugate
anion A– [9,12]. However, all weak acids in a given solution
can be inserted into Henderson–Hasselbalch-type equations
to calculate the pH (Fig. 2).
The second dissociation of phosphate can be used in plasma
in a similar way to bicarbonate as Henderson showed in
1908 [10]. The reason for this phenomenon is that for a
single solution of several weak acids, all the weak acids are in
equilibrium with a single pool of hydrogen ions; the isohydric
principle (Fig. 2) [11]. In physiology, the importance of the
isohydric principle is that, while the ratio of carbon dioxide to
bicarbonate can describe the acid–base status, it is not
necessarily the primary underlying mechanism for both the
respiratory and metabolic components [12].
The rise of bicarbonate
The Van Slyke definition of an acid [9] was the dominant
approach until about 1955 [13–15]. The shift in thinking in
the mid-1950s appears to have followed a desire for clinical
chemistry to embrace the ‘modern’ Bronsted–Lowry definition
of an acid [15]. Using the Bronsted–Lowry definition, many
physiologists confined their thinking on control of hydrogen
ions to weak acids and their conjugate anions, particularly
bicarbonate ions.
Proponents of the Bronsted–Lowry approach [7,15,16]
downplayed that the Van Slyke definition was, in parallel with
the Bronsted–Lowry definition, valid for aqueous biological
solutions [9]. The proponents dismissed defining chloride as
an acid and sodium as a base because these definitions were
old-fashioned and confusing [7,15,16]. The proponents felt
that the older approach did not pay due recognition to the
central, direct role of hydrogen ions. They felt that there was
an insufficient link between electrolytes such as sodium and
chloride and subsequent changes in hydrogen ions. None,
however, examined the role of water as a hydrogen ion
source, as Stewart later did [17].
The proponents of the new Bronsted–Lowry-related
approach could not prove, however, that the previous
approach was wrong. Subsequently, while accepting only
Bronsted–Lowry acids while looking for factors controlling
the nonrespiratory component of acid–base physiology (and
looking for simplicity in a time before calculators), many
researchers focused on the plasma bicarbonate concentration
and the Henderson–Hasselbalch equation (Fig. 1) [4]. This
was the beginning of the still dominant concept that plasma
bicarbonate is not only an indicator of acid–base status, but
also a principal determinant [11]. The issue of which came
first, a change in electrolytes or a change in bicarbonate,
went to the heart of the debate in the 1950s [15]. It is now at
the heart of the debate over the Stewart approach to
acid–base physiology almost half a century later [18,19].
All have agreed for decades that changes in the partial
pressure of carbon dioxide directly lead to changes in a
patient’s acid–base status [8]; either respiratory acidosis or
respiratory alkalosis. Debate has, however, centred on the
nonrespiratory (metabolic) component of a patient’s
acid–base status and the role of bicarbonate [18–20]. By the
1930s it was recognized that an increase in the partial
pressure of carbon dioxide also led physiological (rather than
physical chemical) mechanisms to increase the plasma
bicarbonate concentration [8].
More than 20 years later, at the beginning of the polio
epidemic, Danish physicians used the plasma bicarbonate
Figure 1
The Henderson–Hasselbalch equation. pH, plasma pH; pKa, negative
logto base 10 of the apparent, overall dissociation constant of
carbonic acid; [HCO3
–], plasma bicarbonate concentration; α,
solubility of carbon dioxide in blood at 37°C; pCO2, partial pressure of
carbon dioxide in blood.





The isohydric principal expressed in (a) the law of mass action form
and (b) the Henderson–Hasselbalch form. Because all weak acids in a
solution are in equilibrium with a single pool of hydrogen ions, the ratio
of any of the conjugate anion and its undissociated acid will be able to
describe the pH. 
(a)     H2CO3 ↔ HCO3
– + H+ + HPO4
2– ↔ H2PO4
–








concentration (total carbon dioxide content) alone, and as a
consequence incorrectly diagnosed metabolic alkalosis rather
than respiratory acidosis [4]. These errors were quickly
detected and led Danish researchers to aggressively pursue a
clinically useful method to determine at least two of the three
components of the Henderson–Hasselbalch equation (the pH
and the partial pressure of carbon dioxide) to calculate the
third (the plasma bicarbonate concentration) [4].
Several groups searched for methods to better assess the
metabolic component of acid–base status [4]. Singer and
Hastings [14] introduced the buffer base in 1948 in an
attempt to identify acid–base changes independent of carbon
dioxide. The buffer base is the sum of weak acid (buffer)
anions in plasma including albumin anions and bicarbonate.
Singer and Hastings defined fixed acids as nonbuffer anions,
chloride being one. More than 10 years later, other workers
pursued bicarbonate-centred assessments of the metabolic
component. Base excess and bicarbonate ‘rules of thumb’
were developed in an attempt to isolate primary changes in
the intimately linked variables of carbon dioxide and
bicarbonate [12]. Both base excess and bicarbonate ‘rules of
thumb’ used a bicarbonate-centred approach [4,5,9].
The great trans-Atlantic debate
Siggaard-Andersen, from Copenhagen, developed base
excess in the late 1950s after examining titrations of human
blood. Base excess can be defined as the amount of strong
acid (in mmol/l) that must be added to the blood sample to
return the sample to pH 7.40 after equilibration while
maintaining the partial pressure of carbon dioxide at
40 mmHg [21]. If blood has a pH of 7.40 and a partial
pressure of carbon dioxide of 40 mmHg, therefore, the base
excess will be 0 mmol/l. Siggaard-Andersen developed a
nomogram [9] to determine base excess in the clinical
setting. This nomogram has been mathematically transcribed
(the Van Slyke equation) to allow calculation by blood gas
machines [22].
Schwartz and Relman from Boston argued that deriving
plasma base excess from blood in vitro was inaccurate [23].
First, plasma in vivo is in continuity with interstitial fluid that
has less buffer capacity. Siggaard-Andersen dealt with this
argument by assuming a haemoglobin concentration of
50 g/l, thus reducing the apparent buffer capacity of the
blood  in vitro. The subsequent base excess estimate is
known as ‘standard base excess’ [20]. The second problem
was that in patients with chronic elevation of the partial
pressure of carbon dioxide, the base excess approach
diagnosed a coexisting alkalinizing metabolic process
decreasing the acidity. One approach to this problem was
modifying the base excess nomogram [9]. Another approach
was to develop a correction factor [24].
Disagreement between Americans and Danes over the
usefulness of base excess led to the ‘Great Trans-Atlantic
Acid–Base Debate’ [25]. Instead of base excess the
Americans offered six ‘rules-of-thumb’ to correct changes in
the partial pressure of carbon dioxide or bicarbonate
concentration for changes in the other [11,20,26]. These
rules described the physiological compensation to acid–base
changes to optimize acid–base homeostasis. Having allowed
for expected physiological compensation, residual changes in
carbon dioxide or bicarbonate are then seen as the
mechanisms for changes in acid–base status. Reflecting the
strength of the debate, some current texts [11,26] do not
mention base excess despite its apparent advantage of
simplicity [20].
Stewart
In the late 1970s and early 1980s, Peter Stewart proposed
that the generalized Arrhenius definition of an acid, with
Naunyn’s ideas, is more useful to acid–base physiology than
the Bronsted–Lowry definition [17,27,28].
Stewart introduced an approach to acid–base physiology
and disorders with elements of previous ideas but packaged
in a new way [17]. Stewart’s main reason for exploring
acid–base physiology was that he found the bicarbonate-
centred approach confusing and inadequate.
Using several principles of physical chemistry (particularly
elctroneutrality, conservation of mass, and dissociation of
electrolytes), Stewart produced an approach to acid–base
physiology with a strong relationship to the approaches of
Van Slyke [8] and of Singer and Hastings [14]. Stewart’s
model has three independent controlling variables: the partial
pressure of carbon dioxide, the strong ion difference, and the
total weak-acid concentration [17,28]. The concentrations of
bicarbonate and hydrogen ions are dependent on these three
factors, in association with the (temperature-dependent)
dissociation constants of the weak acids and water (Fig. 3).
The two most important strong ions (completely dissociated
ions) in plasma are sodium and chloride [17,28,29]. The most
important weak acid (partly dissociated acid) is albumin, with
a minor effect from phosphate [29]. Stewart felt that the
major use for bicarbonate and base excess was to determine
the extent of a clinical acid–base disorder rather than the
mechanism [17].
Potential clinical implications
The Stewart approach appears to provide more straight-
forward explanations than the bicarbonate-centred approaches
for many acid–base phenomena seen in the critical care
setting [30,31]. This includes explanations for metabolic
alkalosis associated with decreased plasma albumin concen-
trations [32,33], the mechanism of hyperchloremic acidosis
[34], and the role of ammonia in acid–base homeostasis [30].
The Stewart approach has refined detecting unmeasured
ions. Figge and colleagues [35] demonstrated that the
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traditional calculation of the anion gap does not allow for the
large changes in plasma albumin concentration often seen in
critically ill patients. Subsequently, unless a correction factor
is used, the true incidence of an increased anion gap may go
unrecognized [31,36]. The strong ion gap [37] uses
Stewart’s approach to develop a more complete picture of
the anion gap.
Another approach to detecting unmeasured ions is to
examine the base excess effects of the sodium chloride
strong ion difference and the albumin weak acid effect [29].
These effects are then subtracted from the standard base
excess to give the base excess effect of unmeasured ions.
This approach combines the clinical utility of using base
excess with Stewart’s insights to underling mechanisms
[38,39]. The bicarbonate ‘rules of thumb’ are not as easily
amenable to this kind of quantitative analysis.
The Stewart approach may provide a better understanding of
not only the mechanisms of acid–base disorders, but also the
various management strategies including fluid management
[34,40,41], buffer therapy [42], and renal replacement
therapy [43]. With time, the Stewart approach is being
refined [44,45]. Stewart’s work, like the great trans-Atlantic
debate, has had its detractors [18]. There is currently no
clear strategy to determine which of the ‘modern’ approaches,
the Stewart approach [17] or the bicarbonate-centred
approach [16], is the correct one; however, sodium chloride
dilution studies may be one worthwhile area for study [46].
Measuring the unmeasured ions in critically ill patients is
another area of ongoing interest.
A clinical example
An example will allow a review of this acid–base history and
some of the implications for bedside work. A patient returned
to our intensive care unit after a complex liver transplant.
Blood gasses and arterial electrolytes were taken on arrival.
The blood gas results for Siggaard-Andersen’s approach
were a pH of 7.19, a partial pressure of carbon dioxide of
48 mmHg, and a base excess of –10.1 mmol/l. From this we
may conclude that there is a marked acidemia due to a
respiratory acidosis and a (quantified) metabolic acidosis.
The bicarbonate level was 18 mmol/l. If we use the ‘rules of
thumb’, again there is a respiratory acidosis; the partial
pressure of carbon dioxide has increased by 8 mmHg from
40 mmHg, which is almost 10 mmHg. If there were compensa-
tion we would expect the bicarbonate level to increase by
about 1 mmol/l and the expected bicarbonate would be
25 mmol/l [11]. The actual bicarbonate measured was
18 mmol/l; we therefore conclude there is a (unquantified)
metabolic acidosis.
The anion gap assists both the base excess and ‘rules of
thumb’ approach to assess the source of the acidosis. The
other anion gap variables were: sodium, 145 mmol/l; potassium,
4.5 mmol/l; and chloride, 111 mmol/l. On first inspection the
increased chloride suggests the possibility of an unquantified
hyperchloremic metabolic acidosis. The calculated anion gap
was 20.5 mmol/l, suggesting a possible role for unmeasured
anions. However, the plasma albumin concentration was only
10 g/l which is likely to mask the true size of the anion gap.
Using Figge and colleagues’ correction [35] the anion gap
becomes 28.5 mmol/l.
The actual anion gap is therefore considerably larger than the
uncorrected anion gap. One component of this gap will be
the lactate of 3.7 mmol/l. Therefore, using either of the bi-
carbonate-centred approaches, we conclude that bicarbonate
has decreased in part through increased lactic acidosis,
through hyperchloremic acidosis, and through other unknown
acids. The relative contributions of these variables to the
acidosis remain unquantified.
Many clinicians using the Stewart approach would integrate
the Siggaard-Anderson approach and conclude that there is
a respiratory acidosis and a quantified metabolic acidosis of
–10 mmol/l. The difference between the principal plasma
strong ions, sodium and chloride, is 34 mmol/l, which has an
acidifying base excess effect of –4 mmol/l assuming the
reference value is 38 mmol/l [38]. This acidosis is offset by an
alkalinizing albumin base excess effect of 8 mmol/l assuming
a normal albumin value of 42 g/l [38]. This leaves an
unmeasured ion effect on base excess of –14.5 mmol/l.
Lactate, another strong anion, will have a base excess effect
of –3.7 mmol/l. Phosphate is a weak acid. The plasma
phosphate concentration was 1.7 mmol/l and will have a base
excess effect of –3.1 mmol/l [30]. Confirming an important
effect of unmeasured ions, the strong ion gap [37] was
8.6 mEq/l given that the plasma magnesium concentration
was 0.57 mmol/l and the plasma ionized calcium
concentration was 1.17 mmol/l.
If one chose to treat the acidemia, the respiratory acidosis
can be dealt with through greater ventilation. On the meta-
bolic side, there is a decreased strong ion difference acidosis.
The strong ion difference can be widened (alkalizing) by
maintaining a high normal sodium, possibly by using sodium
bicarbonate, while decreasing the chloride through careful
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use of intravenous fluids [34] and possibly furosemide to
increase chloride excretion [47]. If we chose to, we could
limit further acidosis by limiting the use of albumin, a weak
acid; particularly if the supporting solution is sodium chloride.
Alkalosis will occur as the liver removes lactate from the
plasma as a direct effect [30], not because of bicarbonate
formation [48].
In the present patient, unmeasured anions included gelatin as
a weak acid, from intravenous colloid therapy [49], as well as
acetate and gluconate, strong anions, from Plasmalyte [34].
Removal of these substances from the plasma by the kidney
or the liver will be directly alkalizing because less gelatin will
decrease the amount of weak acid in plasma, and less
acetate and gluconate will widen the strong ion difference.
The Stewart approach closely integrates acid–base physio-
logy and clinical chemistry, providing detailed clinical strategies
to manage acid–base disorders. The bicarbonate-centred
strategies are less integrated with general plasma chemistry
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